Successful development of siRNA therapies has significant potential for the treatment of skin conditions (alopecia, allergic skin diseases, hyperpigmentation, psoriasis, skin cancer, pachyonychia congenital) caused by aberrant gene expression. Although hypodermic needles can be used to effectively deliver siRNA through the stratum corneum, the major challenge is that this approach is painful and the effects are restricted to the injection site. Microneedle arrays may represent a better way to deliver siRNAs across the stratum corneum. In this study, we evaluated for the first time the ability of the solid silicon microneedle array for punching holes to deliver cholesterol-modified housekeeping gene (Gapdh) siRNA to the mouse ear skin. Treat...
Microneedle delivery of nucleic acids, in particular plasmid DNA (pDNA), to the skin represents a po...
Purpose Microneedles disrupt the stratum corneum barrier layer of skin creating transient pathways ...
Cutaneous delivery of macromolecules is significantly impeded by the inherent barrier properties of ...
The development of siRNA-based gene silencing therapies has significant potential for effectively tr...
The skin presents an attractive target for the delivery and expression of plasmid DNA pDNA. Potentia...
The stratum corneum (SC) represents a significant barrier to the delivery of gene therapy formulatio...
Microneedle arrays increase skin permeability by forming channels through the outer physical barrier...
The delivery of nucleic acid therapies to their intracellular target site is one of the greatest ch...
International audienceMicroneedle devices have been proposed as aminimally invasive delivery system ...
Nucleic acid therapies may have significant potential for effectively treating genetic, hyper-proli...
Microneedle delivery of nucleic acids, in particular plasmid DNA (pDNA), to the skin represents a po...
Purpose Microneedles disrupt the stratum corneum barrier layer of skin creating transient pathways ...
Cutaneous delivery of macromolecules is significantly impeded by the inherent barrier properties of ...
The development of siRNA-based gene silencing therapies has significant potential for effectively tr...
The skin presents an attractive target for the delivery and expression of plasmid DNA pDNA. Potentia...
The stratum corneum (SC) represents a significant barrier to the delivery of gene therapy formulatio...
Microneedle arrays increase skin permeability by forming channels through the outer physical barrier...
The delivery of nucleic acid therapies to their intracellular target site is one of the greatest ch...
International audienceMicroneedle devices have been proposed as aminimally invasive delivery system ...
Nucleic acid therapies may have significant potential for effectively treating genetic, hyper-proli...
Microneedle delivery of nucleic acids, in particular plasmid DNA (pDNA), to the skin represents a po...
Purpose Microneedles disrupt the stratum corneum barrier layer of skin creating transient pathways ...
Cutaneous delivery of macromolecules is significantly impeded by the inherent barrier properties of ...